CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.01065
+0.00065 (6.50%)
At close: Aug 11, 2026
CERO Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -20.7 | -19.92 | -8.3 | -7.29 | -0.67 | -0 |
Depreciation & Amortization | 0.27 | 0.28 | 0.44 | 0.46 | - | - |
Stock-Based Compensation | 3.12 | 1.96 | 0.93 | 0.1 | - | - |
Other Adjustments | 0.94 | 1.41 | -7.82 | 0.4 | -2.84 | - |
Changes in Accounts Payable | 1.31 | 2.27 | 0.26 | 1.28 | 1.64 | 0 |
Changes in Accrued Expenses | 0.03 | -0.41 | 2.29 | 0.04 | - | - |
Changes in Income Taxes Payable | - | - | - | - | 0.52 | - |
Changes in Other Operating Activities | -1.06 | -1.67 | -0.71 | -0.78 | 0.25 | - |
Operating Cash Flow | -14.4 | -16.08 | -12.92 | -5.79 | -1.09 | 0 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Purchases of Investments | - | - | - | - | -0.33 | - |
Proceeds from Sale of Investments | - | 0.5 | - | - | 181.16 | - |
Investing Cash Flow | - | 0.5 | - | - | 180.84 | - |
Short-Term Debt Issued | - | - | 0.41 | - | - | - |
Short-Term Debt Repaid | - | - | -0.4 | - | - | - |
Net Short-Term Debt Issued (Repaid) | - | - | 0.01 | - | - | - |
Long-Term Debt Issued | - | - | 0.01 | 0.61 | 0.65 | - |
Long-Term Debt Repaid | - | - | -0.02 | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | - | -0.01 | 0.61 | 0.65 | - |
Issuance of Common Stock | 4.38 | 9.43 | 4.81 | 0.01 | - | - |
Repurchase of Common Stock | - | - | - | - | -139.35 | - |
Net Common Stock Issued (Repurchased) | 4.38 | 9.43 | 4.81 | 0.01 | -139.35 | - |
Issuance of Preferred Stock | - | 4.99 | 8.92 | - | - | - |
Repurchase of Preferred Stock | - | -0.4 | - | - | - | - |
Net Preferred Stock Issued (Repurchased) | - | 4.59 | 8.92 | - | - | - |
Other Financing Activities | - | -0.11 | - | -0.04 | - | - |
Financing Cash Flow | 9.55 | 13.92 | 13.73 | 0.57 | -138.7 | - |
Net Cash Flow | -4.35 | -1.66 | 0.81 | -5.22 | 41.04 | 0 |
Free Cash Flow | -14.4 | -16.08 | -12.92 | -5.79 | -1.09 | 0 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.27 | -3.80 | -445.81 | - | -98.14 | - |
Levered Free Cash Flow | -89.52 | -95.06 | -8.81 | -5.68 | 2.39 | 0 |
Unlevered Free Cash Flow | -17.81 | -17.99 | -13.92 | -6.67 | 47.37 | 0 |